Get Published | Subscribe | About | Write for Our Blog    

News RSS Bioethics News.


Biogen’s top scientist nearly dares FDA not to approve Alzheimer’s drug

External Link - Source: STAT

Biogen’s top scientist offered unflinching support Thursday for the efficacy of the company’s controversial Alzheimer’s drug called aducanumab, shrugging off outside skepticism and almost daring regulators not to approve it.

This entry was posted in Pharmaceuticals, Science. Bookmark the permalink.